Kurata A, Yamauchi K, Watanabe T, Nonaka M, Abe R, Okumura K, Tada T
Department of Immunology, Faculty of Medicine, University of Tokyo, Japan.
J Mol Cell Immunol. 1984;1(4):267-77.
Recent studies in molecular genetics have revealed the striking fact that the previously known I-J subregion (or I-J gene) does not exist at the exactly prescribed position in the I-region of the murine major histocompatibility complex (MHC). How, then, can we comprehend the established serological and functional significance of I-J genes and I-J products? To answer this question we reexamined systematically the specificities and functional activities of monoclonal anti-I-J antibodies. A series of monoclonal anti-I-Jk antibodies were newly established by fusion of B10.A(3R) spleen cells immune to B10.A(5R) lymphoid cells with P3X63-Ag8-653. Their abilities to eliminate known functions of T cell subsets and to react with I-J+ T cell clones of defined functions were examined in an in vitro secondary antibody response and by fluorescence-activated cell sorter analysis. The monoclonal antibodies (mAb) were divided into three groups: (1) those reactive with suppressor inducer T cells (Tsi), Tsi hybridomas, and the antigen-specific T cell factor (TsF) derived from them; (2) those specific for suppressor effector T cells (Tse) and Tse clones; and (3) those reactive with some but not all helper T cells. The determinants detected by these three different groups of antibodies are apparently present on separate, nonoverlapping cell populations and functionally distinct clones. The above results indicate the multiplicity of I-J products expressed on different T cell subsets, and sharply contradict the notion, derived from molecular genetics, that not even a single gene can be accommodated in the I-J subregion. To resolve this dilemma, we compared the above results with those obtained with another set of mAb that also detected I-region-controlled determinants on augmenting and helper T cells. Although the specificities of these mAb clearly mapped to within the I-region, none of them reacted with conventional class II Ia antigens of B cells and macrophages. The common properties shared by these anti-Ik and anti-I-Jk antibodies are that (1) they react only with T cells and T cell clones with I-region-controlled functions; (2) they can block some of the Ia-restricted cell interactions, including those of helper and suppressor T cells; and (3) they inhibit the syngeneic and/or allogeneic mixed lymphocyte reaction (MLR) by blocking the responder but not the stimulator cells.(ABSTRACT TRUNCATED AT 400 WORDS)
最近的分子遗传学研究揭示了一个惊人的事实,即先前已知的I-J亚区(或I-J基因)在小鼠主要组织相容性复合体(MHC)的I区中并不存在于确切规定的位置。那么,我们如何理解I-J基因和I-J产物已确定的血清学和功能意义呢?为了回答这个问题,我们系统地重新审视了单克隆抗I-J抗体的特异性和功能活性。通过将对B10.A(5R)淋巴细胞免疫的B10.A(3R)脾细胞与P3X63-Ag8-653融合,新建立了一系列单克隆抗I-Jk抗体。在体外二次抗体反应中以及通过荧光激活细胞分选分析,检测了它们消除已知T细胞亚群功能以及与具有确定功能的I-J+T细胞克隆反应的能力。这些单克隆抗体(mAb)分为三组:(1)与抑制诱导T细胞(Tsi)、Tsi杂交瘤以及源自它们的抗原特异性T细胞因子(TsF)反应的抗体;(2)对抑制效应T细胞(Tse)和Tse克隆具有特异性的抗体;(3)与部分但不是所有辅助性T细胞反应的抗体。这三组不同抗体检测到的决定簇显然存在于不同的、不重叠的细胞群体和功能不同的克隆上。上述结果表明在不同T细胞亚群上表达的I-J产物具有多样性,这与分子遗传学得出的观点形成了鲜明矛盾,即I-J亚区甚至无法容纳单个基因。为了解决这一困境,我们将上述结果与另一组mAb的结果进行了比较,这组mAb也检测到了增强性T细胞和辅助性T细胞上I区控制的决定簇。尽管这些mAb的特异性明确定位于I区内,但它们均不与B细胞和巨噬细胞的传统II类Ia抗原反应。这些抗Ik和抗I-Jk抗体共有的特性是:(1)它们仅与具有I区控制功能的T细胞和T细胞克隆反应;(2)它们可以阻断一些Ia限制的细胞相互作用,包括辅助性和抑制性T细胞的相互作用;(3)它们通过阻断反应细胞而非刺激细胞来抑制同基因和/或异基因混合淋巴细胞反应(MLR)。(摘要截断于400字)